I have been pondering if I should buy into Biogen Idec (BIIB). They have a strong pipeline and I have a feeling that Biogen's MS drug Tysabri will be available in the second half of 2006. This can only be positive for Biogen's Stock price. I am considering exiting my position in Motorola (MOT) and covering my short in China Natural Resources (CHNR) to fund my purchase. If I do go through with the transaction, I will post it to the blog.